The use of AI in drug discovery and development has been recognised, explored, and implemented throughout the last decade, ...

Artificial intelligence continues stirring things up in chemistry. To wit: YC-backed Cambridge, U.K.-based ReactWise is using ...

Seeking more efficient drug development, pharmaceutical giants and startups are encouraging AI fluency and in some cases ...

Traditional approaches to benchmarking brand performance have struggled to keep pace with industry dynamics. While individual ...

During a health-focused event in New York on Tuesday, Google announced that it's developing a collection of "open" AI models ...

In addition to a continued focus on growing drug pipelines, and the increasing use of artificial intelligence (AI) and data ...

42 Technology (42T) has joined forces with industry leaders in machine vision, edge AI silicon and software – Balluff, ...

Pharma brands that fail to evolve risk losing relevance in a world where patients demand more control, transparency, and ...

Brand.com’s are connecting HCPs to information, with fewer hoops to jump through, courtesy of new digital tools promising to ...

As a result, lucrative deals have been struck between big pharma companies and specialist AI companies. These include the $2.76bn deal between Novo Nordisk and Valo Health, the $1.75bn agreement ...